A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: Assay reproducibility and interindividual variability

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3411-3418

  Falk, Roni T ^a   Xu, Xia ^b   Keefer, Larry ^c   Veenstra, Timothy D ^b   Ziegler, Regina G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRONE; CATECHOL ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; AGED; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, LIQUID; ESTROGENS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57449110175     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0355     Document Type: Article

References (35)

1. Key T, Appleby P, Barnes I, et al.; Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
2. Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Endocr Relat Cancer 2005;12:1071-82.
3. Key TJ, Wang DY, Brown JB, et al. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 1996;73:1615-9.
4. Onland-Moret NC, Kaaks R, van Noord PAH, et al. Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. Br J Cancer 2003;88:1394-9.
5. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
6. Zhu BT, Lee AJ. NADPH-dependent metabolism of 17β-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. Steroids 2005;70:223-44.
7. Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl 1980;232:1-127.
8. Fishman J, Martucci CJ. Biological properties of 16α- hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin Endocrinol Metab 1980;51:611-5.
9. Bradlow L, Telang NT, Osborn MP. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters. Adv Exp Med Biol 1996;387:285-96.
10. Ziegler RG, Rossi SC, Fears TR, et al. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestrone in urine. Environ Health Perspect 1997;105:607-14.
11. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21:40-54.
12. Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
13. Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor and β subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 2006;147:4132-50.
14. Falk RT, Gail MH, Fears TR, et al. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in preand postmenopausal women. Cancer Epidemiol Biomarkers Prev 1999;10:567-77.
15. Stanczyk FZ, Lee JS, Santen RJ. Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol Biomarkers Prev 2007;16:1713-9.
16. Adlercreutz H, Kiuru P, Rasku S, Wahala K, Fotsis T. An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine. J Steroid Biochem Mol Biol 2004;92:399-411.
17. Xu X, Veenstra TD, Fox SD, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 2005;77:6646-54.
18. Xu X, Keefer LK, Ziegler RG, Veenstra TD. A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc 2007;2:1350-5.
19. Taylor JI, Grace PB, Bingham SA. Optimization of conditions for the enzymatic hydrolysis of phytoestrogen conjugates in urine and plasma. Anal Biochem 2005;341:220-9.
20. Peake M, Whiting M. Measurement of serum creatinine - current status and future goals. Clin Biochem Rev 2006;27:173-84.
21. Gail MH, Fears TR, Hoover RN, et al. Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. Cancer Epidemiol Biomarkers Prev 1996;10:835-44.
22. SAS Institute. SAS/STAT user's guide, version 8. Cary (NC): SAS Institute; 1999.
23. Zhu BT, Conney AH. Is 2-methoxyestradiol and endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 1998;58:2269-77.
24. Newman SP, Ireson CR, Tutill HJ, et al. The role of 17β- hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Res 2006;66:324-30.
25. Mueck AO, Seeger H, Lippert TH. Estradiol metabolism and malignant disease. Maturitas 2002;43:1-10.
26. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003;23:165-72.
27. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
28. Lee AJ, Kosh JW, Conney AH, Zhu BT. Characterization of the NADPH-dependent metabolism of 17β-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther 2001;298:420-32.
29. Lee AJ, Mills LH, Kosh JW, Conney AH, Zhu BT. NADPH-dependent metabolism of estrone by human liver microsomes. J Pharmacol Exp Ther 2002;300:838-49.
30. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspective. Carcinogenesis 1998;19:1-27.
31. Castagnetta L, Granata OM, Cocciadiferro L, et al. Sex steroids, carcinogenesis, and cancer progression. Ann NY Acad Sci 2004;1028:233-46.
32. Brooks JD, Ward WE, Lewis JE, et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004;79:318-25.
33. Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988;52:69-83.
34. De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA. Responsiveness of plasma 2-and 4-hydroxycatecholestrogens to training and to graduate submaximal and maximal exercise in an untrained woman. Interuniversity Project on Reproductive Endocrinology in Women and Exercise. Int J Sports Med 1998;19:20-5.
35. Klug TL, Bågeman E, Ingvar C, Rose C, Jernström H. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels. Mol Genet Metab 2006;89:381-9.